In vitro data suggest that hyperglycaemia and hyperlipidaemia inhibited the expression of MICU1-regulating transcription factor Sp1, while MICU1 over-expression increases mitochondrial Ca2+ uptake and inhibits ROS production through enhancing the NADPH-dependent antioxidant system [67]. The gene discussed is MICU1; the disease is hyperlipidemia.